# Rybrevant

NDC: 57894-501
Generic name: amivantamab-vmjw
Labeler / Manufacturer: Janssen Biotech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210521

FDA application: BLA761210

## Active ingredients

- AMIVANTAMAB: 350 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57894-501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57894-501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1466c070-9f97-4fa4-a955-6a6b59981fb8